Frederik Marme

Articles by Frederik Marme

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)

ByHope S. Rugo, MD,Cristina Saura,Komal Jhaveri,Carlos Barrios,Sherene Loi, MD, PhD,Frederik Marme,Francois Clement Bidard,Yeon Hee Park,Peter Schmid, MD,Sarah L. Sammons,Giuseppe Curigliano

May 8th 2026

Latest Updated Articles

Trending on CancerNetwork

Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs

PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer

Rusfertide Earns Category 1 NCCN Recommendation in Polycythemia Vera

AdenoVerse Platform Receives FDA Designation for HPV-Associated Cancers

Novel Monoclonal Antibody Wins FDA Fast Track Designation in High-Risk MDS